Allena Pharmaceuticals Inc (ALNA)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

ONE NEWTON EXECUTIVE PARK NEWTON, MA 02462

Allena Pharmaceuticals, Inc. operates as a late-stage clinical bio-pharmaceutical company. The Company develops oral enzyme therapeutics to treat patients. Allena Pharmaceuticals also focuses on treating metabolic and orphan diseases such as oxalate and urate. Allena Pharmaceuticals serves patients in the United States.

Data as of 2020-07-04
Market Cap49.588 Million Shares Outstanding32.2 Million Avg 30-day Volume1.078 Million
P/E Ratio Dividend Yield EPS-1.89
Price/Sales Price cash flow ratio Price free cash flow ratio-1.7
Book Value0.33 Price to Tangible Book4.65 Alpha
Short Interest Ratio % Short Interest to Float R-squared
BETA 52-week High/Low6.3 / 0.525 Stddev
View SEC Filings from ALNA instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 2 0 (0.0%)
13F Filers holding this stock: 31 12 (0.79%)
Aggregate 13F shares on 03/31/2020: 14.522 Million 3.207 Million
Aggregate 13F shares on 12/31/2019: 14.452 Million 3.173 Million
Percent change: 0.49% 1.06%
Funds creating new positions: 9 3
Funds Adding to an existing position: 6 3
Funds closing out their position: 4
Funds reducing their position: 7 4
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ALNA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ALNA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TEPPER ROBERT I

  • Director
  • 10% Owner
0 2020-06-26 0

HACK ANDREW A. F.

  • Director
0 2020-06-25 0

BESSEMER VENTURE PARTNERS VII L.P.

BESSEMER VENTURE PARTNERS VII INSTITUTIONAL L.P.

BVP VII SPECIAL OPPORTUNITY FUND LP

DEER VII & CO. L.P.

DEER VII & CO. LTD.

  • 10% Owner
0 2020-06-10 0

BOLTE AXEL

  • Director
0 2020-06-09 0

SANTINI GINO

  • Director
41,473 2020-06-02 0

BRENNER LOUIS MD PRESIDENT AND CEO

  • Officer
  • Director
0 2020-05-28 2

WHOLIHAN EDWARD CHIEF FINANCIAL OFFICER

  • Officer
0 2020-05-28 2

TOPPER JAMES N

  • Director
  • 10% Owner
0 2020-05-21 0

HADLEY HARBOR MASTER INVESTORS (CAYMAN) L.P.

  • 10% Owner
4,962,678 2020-03-24 0

ALEXANDER ROBERT CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
477,577 2019-11-29 0

MARGOLIN ALEXEY L

  • Director
0 2019-06-05 0

DIAZ ALLENE M.

  • Director
0 2019-05-06 0

FHM VI, L.L.C.

FHM VI, L.P.

FRAZIER HEALTHCARE VI, L.P.

  • 10% Owner
1,396,615 2018-12-07 0

THIRD ROCK VENTURES II, L.P.

THIRD ROCK VENTURES GP II, L.P.

TRV GP II, LLC

LEVIN MARK J

STARR KEVIN P

  • 10% Owner
2,790,964 2017-11-06 0

HBM BIOCAPITAL II LP

  • 10% Owner
No longer subject to file 2017-11-06 0

KRAUS STEPHEN

  • Director
0 2017-11-06 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

BRENNER LOUIS MD - Director - Officer PRESIDENT AND CEO

2020-05-28 A 123,966 a 123,966 0.00 direct

WHOLIHAN EDWARD - Officer CHIEF FINANCIAL OFFICER

2020-05-28 A 82,411 a 82,411 0.00 direct

BRENNER LOUIS MD - Director - Officer PRESIDENT AND CEO

2020-05-28 A 123,966 a 123,966 0.00 direct

WHOLIHAN EDWARD - Officer CHIEF FINANCIAL OFFICER

2020-05-28 A 82,411 a 82,411 0.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments